January 14, 2018

Nature Article Series: Growing Pains for Gene Therapy Manufacturing

Vigene has partnered with Nature to create a four-part series of articles highlighting new production strategies and technologies that are […]
November 7, 2017

Vigene Biosciences Partners with The Michael J. Fox Foundation to Distribute Alpha-synuclein Knockdown Viral Vectors for Parkinson’s Disease Research

ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, today announced a […]
November 1, 2017

Vigene Biosciences and Mila’s Miracle Foundation announce partnership on Gene therapy for CLN7 Batten Disease

A race to save children’s lives from a devastating neurodegenerative disorder ROCKVILLE, Md. ROCKVILLE, Maryland – Vigene Biosciences, Inc. (Vigene), a […]
November 29, 2016

Vigene Biosciences Acquires the cGMP Manufacturing Facility and Assets of Omnia Biologics

Vigene Biosciences, Inc. (Vigene), a leading biotechnology company for viral vector production and development, announced today that the company has […]